Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Dow Climbs as Value Stocks Race Higher on Positive Vaccine News

Published 23/11/2020, 18:30
Updated 23/11/2020, 18:39
© Reuters

© Reuters

By Yasin Ebrahim

Investing.com - The Dow climbed Monday, as positive vaccine news and better-than-expected economic data underpinned a rally in value stocks.

The Dow Jones Industrial Average rose 0.75%, or 219 points. The S&P 500 was up 0.34%, while the Nasdaq Composite added 0.18%.

AstraZeneca (NASDAQ:AZN) said its clinical trials showed its Covid-19 vaccine was 70% effective in protecting against the virus. That was below the efficacy rate of rival vaccines from Pfizer (NYSE:PFE), and Moderna (NASDAQ:MRNA).  The trial involved two dosing regiments, one of which showed a 90% efficacy rate, and the other with 62%.

In another boost in the fight against the virus, Regeneron's coronavirus antibody cocktail, used by President Trump when he was hospitalized with Covid-19 last month, was granted emergency use authorization by the Food and Drug Administration. Regeneron Pharmaceuticals (NASDAQ:REGN) shares were flat.

The backdrop of positive coronavirus treatment-related news prompted investors to up their bets on airlines, banks, and cruise operators – sectors hit hard by the pandemic amid global restrictions to curb the virus.

United Airlines (NASDAQ:UAL), Delta Air Lines (NYSE:DAL), and American Airlines Group (NASDAQ:AAL) were sharply higher.

Energy, meanwhile, surged nearly 5% on hopes a quicker end to the pandemic could shore up demand. Occidental Petroleum (NYSE:OXY) led the gains in the sector, up 13%.

As well as the positive vaccine news,  optimism over stimulus lifted investor sentiment on stocks. 

A spokesman for Joe Biden’s presidential transition denied a report that the president-elect was in favor of a smaller fiscal package to ensure a speedier passage through Congress. "This is incorrect. The President-elect fully supports the Speaker and Leader in their negotiations," Biden transition spokesman Andrew Bates told HuffPost when asked about the New York Times story on Monday.

Tech, meanwhile, turned positive after falling into the red earlier in the day, as gains in chip stocks, led by Micron Technology (NASDAQ:MU), helped offset mixed weakness in the Fab 5.

Apple (NASDAQ:AAPL), Amazon.com (NASDAQ:AMZN) were about unchanged on the day, while Facebook (NASDAQ:FB), Alphabet (NASDAQ:GOOGL) and Microsoft  (NASDAQ:MSFT) traded lower.

In other news, Snap (NYSE:SNAP) jumped nearly 5% after launching a feature on its platform to rival TikTok and Instagram Reels.

On the economic front, the composite Purchasing Managers' Index, which tracks activity in both manufacturing and services together, rose at its fastest pace since March 2015.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.